Co-Diagnostics: Mark Poritz

Co-Diagnostics has appointed Mark Poritz as CSO. Poritz most recently served as CSO of Idaho Molecular, which Co-Diagnostics acquired at the end of 2021. He previously worked at BioFire Diagnostics (now part of BioMérieux) from 2002 to 2018, playing a key role in the company's growth and development of the FilmArray in vitro diagnostic testing platform, Co-Diagnostics said. The company added that Poritz is a Harvard University- and University of California, San Francisco-educated molecular biologist with more than 30 years of experience in the application of PCR and related methods to gene cloning, drug discovery, infectious disease diagnostics, and aptamer selection.